Policy / Pricing Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated Care Drug ChannelsBy Bryce Platt, PharmD Minnesota's new 340B data reveal a growing disconnect between the program's size and the value Minnesotans receive in return.Policy / PricingRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) Drug Channels By Bryce Platt, PharmD Minnesota’s new 340B data reveal a growing disconnect between the program’s size and the value Minnesotans receive in return. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sanofi receives FDA approval for Tzield in paediatric diabetesNext: AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
